Zouache, M. A. http://orcid.org/0000-0003-3689-7748
Richards, B. T.
Pappas, C. M.
Anstadt, R. A.
Liu, J.
Corsetti, T.
Matthews, S.
Seager, N. A.
Schmitz-Valckenberg, S. http://orcid.org/0000-0003-3358-9942
Fleckenstein, M.
Hubbard, W. C.
Thomas, J.
Hageman, J. L.
Williams, B. L.
Hageman, G. S.
Funding for this research was provided by:
Research to Prevent Blindness (Unrestricted Grant to the Department of Ophthalmology & Visual Sciences, University of Utah., Unrestricted Grant to the Department of Ophthalmology & Visual Sciences, University of Utah.)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R24EY017404)
Additional funding from philanthropic donations to the Steele Center for Translational Medicine, John A. Moran Eye Center, University of Utah.
Article History
Received: 2 February 2023
Accepted: 19 December 2023
First Online: 10 January 2024
Competing interests
: G.S.H. is a shareholder, consultant, and co-founder of Perceive Biotherapeutics, LLC. G.S.H., C.M.P., B.L.W., and B.T.R. are inventors on patents and patent applications owned by the University of Utah. J.L.H. is the spouse of G.S.H. None of the other authors have any relevant proprietary interests.